ALAN H. AUERBACH - 03 Jan 2022 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Alan H. Auerbach
Issuer symbol: PBYI
Transactions as of: 03 Jan 2022
Transactions value $: -$72,923
Form type: 4
Filing time: 05 Jan 2022, 16:12:47 UTC
Previous filing: 06 Dec 2021
Next filing: 03 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBYI	Common Stock	Sale	-$72.9K	-22.9K	-0.52%	$3.19	4.39M	03 Jan 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.17 to $3.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.17 to $3.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.